{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-22-001454","form_type":"8-K/A","ticker":"ACHC","cik":"0001520697","company_name":"Acadia Healthcare Company, Inc.","filed_at":"2022-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.961542+00:00","generated_at":"2026-06-22T18:06:02.004819+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Acadia Q3 revenue $666.7M (+13.5% YoY); adj. EPS $0.86; narrows FY2022 guidance","bullets":["Revenue $666.7M, +13.5% YoY; same facility revenue +10.2% on 6.9% revenue per patient day and 3.1% patient day growth.","Net income $71.1M ($0.78 diluted EPS); adjusted EPS $0.86 ($0.80 excl. Provider Relief Fund income).","Adjusted EBITDA $162.8M (incl. $7.7M PRF); excl. PRF $155.1M.","FY2022 guidance narrowed: revenue $2.58-2.60B; adj. EPS $3.13-3.23 (incl. PRF) / $3.00-3.10 (excl.).","Cash $93.4M, $515M revolver available; net leverage ~2.1x; repaid Medicare advances and payroll tax deferrals."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-22-001454","json":"https://secwatch.observer/filing/0001157523-22-001454.json","markdown":"https://secwatch.observer/filing/0001157523-22-001454.md","text":"https://secwatch.observer/filing/0001157523-22-001454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520697/000115752322001454/0001157523-22-001454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520697/000115752322001454/a52957199.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T18:06:02.004819+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c185ff8e5c57fc37b37f9df7fd9e3285afb5531","claim":"Acadia Healthcare Company, Inc. reported third quarter ended September 30, 2022 results: revenue $666.7 million, net income $71.1 million, EPS $0.78 per diluted share.","evidence_excerpt":"The Company reported revenue of $666.7 million for the third quarter of 2022, compared with $587.6 million for the third quarter of 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1520697/000115752322001454/0001157523-22-001454-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"$666.7 million"},{"label":"Net income","value":"$71.1 million"},{"label":"EPS","value":"$0.78 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}